| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.06 |